UNSPSC 51162321: Acetaminophen/phenylpropanolamine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162321 Acetaminophen/phenylpropanolamine is a Commodity code that in recent state and local solicitations covers pharmaceutical products and related medical supplies — parenteral solutions, intravenous products, and controlled substances for correctional and public health delivery. The Washington State Department of Corrections RFQQ RFQQK13020, posted September 8, 2026 with response due October 7, 2026, solicits parenteral nutrition solutions, IV solutions, and other parenteral products for eight facilities across three regions, with demonstrated capability to prepare and deliver PN bags within 24 hours and other parenteral products within 8 hours. The scope reflects healthcare supply chains serving public custodial and community health settings rather than retail pharmaceutical distribution. Issuing bodies include state corrections agencies and county health departments; the Washington DOC opportunity notes aspirational small business (25%), minority-owned business (10%), women-owned business (6%), and veteran-owned business (5%) participation targets under state RCW Chapter 39.19.

Recent activity concentrates in Washington and Florida. The Washington solicitation anticipates multiple contractor selection across three regions with contract terms through June 30, 2030, while Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026) sought 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the county community health building. Both opportunities require firm fixed pricing, specified insurance coverage including professional liability, and compliance with state business licensing and background clearance requirements. Contractors must meet delivery timelines measured in hours for parenteral products and establish quarterly delivery schedules for public health supplies.